CLINICAL_TRIALS
trial_result
· 2012-03-29
Clinical Trial Update: ELND005 in Patients With Mild to Moderate Alzheimer's Disease [Phase 2]
Summary
A Phase 2 clinical trial update for ELND005 in patients with mild to moderate Alzheimer's disease has completed with results posted in 2012.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: OPKO Health, Inc. | Conditions: Alzheimer Disease | Phase 2 | Status: COMPLETED | Results posted: 2012-03-29